Behind LEQEMBI PROMOTION

宮田満

Eisai, struggling with rising sales, has launched a sales promotion for its Alzheimer's disease drug LEQEMBI. However, the real aim was to increase revenues in non-medical areas in order to secure legitimate value.
https://miyata-bio.net/column/0000327/

この記事が気に入ったらサポートをしてみませんか？